Hepatopulmonary syndrome (HPS) is an under-recognised complication of chronic liver disease, affecting 10%–30% of patients with cirrhosis. It involves intrapulmonary vascular dilatations, arterial ...
Hepatopulmonary Syndrome: Update on Recent Advances in Pathophysiology, Investigation, and Treatment
The diagnosis of HPS depends on establishing that impaired gas exchange in a patient with liver disease is due to pulmonary vascular dilatation. In most cases, the results of arterial blood gases and ...
Patient 1, a 58-year-old man, received eight cycles of intravenous bortezomib followed by combination bortezomib and lenalidomide, and he had only a partial response. He underwent autologous stem-cell ...
The characteristics of hepatopulmonary syndrome include an oxygen saturation < 80%, an increased alveolar-arterial gradient (> 15 mm Hg) while breathing room air, portal hypertension with or without ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results